Invention Grant
- Patent Title: Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
-
Application No.: US15398427Application Date: 2017-01-04
-
Publication No.: US09849117B2Publication Date: 2017-12-26
- Inventor: Dominik Feuerbach , Konstanze Hurth , Timothy John Ritchie , Rochdi Bouhelal
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Hoffman Warnick LLC
- Main IPC: A61K31/439
- IPC: A61K31/439 ; A61K31/44 ; A61K9/20 ; A61K31/444
Abstract:
The present invention relates to 1-aza-bicycloalkyl derivatives of formula I, wherein X is CH2 or a single bond; Y is a group of formula and wherein R has the meanings as defined in the specification, which compounds are alpha 7 nicotinic acetylcholine receptor (nAChR) agonists; to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
Public/Granted literature
- US20170112814A1 AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS Public/Granted day:2017-04-27
Information query
IPC分类:
